Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease (Q43704795)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

chronic liver disease

0 references

author name string

Henning Wolfgang Zimmermann

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Jan Robert Mueller

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sebastian Seidler

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tom Luedde

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Christian Trautwein

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Frank Tacke

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

14 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1-16

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Mechanisms of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Mononuclear cells in liver fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Amelioration of hepatic fibrosis by NK cell activation.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

The composition of intrahepatic lymphocytes: shaped by selective recruitment?

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Senescence of activated stellate cells limits liver fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Human natural killer cells

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural killer cells in human health and disease

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Organ-specific features of natural killer cells

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Ghrelin in chronic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Novel APC-like properties of human NK cells directly regulate T cell activation

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Natural killer cells in liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1159%2F000350821

21 January 2018

Identifiers

10.1159/000350821

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43704795&oldid=2102705055"